Mr. Sandberg has been an Entrepreneur in the area of medical technology for over 20 years. He has primarily focused in the areas of Spine, Orthopedics and Biologics in a variety of capacities. Mr. Sandberg played pivotal roles in early to mid-cap companies including two successful exits: Emerging Implant Technologies (President, US) and Axolotl Biologix (CEO). Due to some early opportunities, Mr. Sandberg was able to have a very broad view of organizational design and commercialization with specialty areas including: Corporate Governance, Building Highly Effective Teams, Commercialization, Market Access and Mergers & Acquisitions. Mr. Sandberg has been a co-founder of 4 other companies in the industry and serves as a Member of the Board of Directors for the following organizations: Surgio Health, OrthoEx, Global Spine Outreach, Axolotl Biologix as well as serving on the commercial advisory board for Moximed.